AAAAAA

   
Results: 1-13 |
Results: 13
Downregulation of Akt1 inhibits anchorage-independent cell growth and induces apoptosis in cancer cells
Authors: Liu, XS Shi, Y Han, EKH Chen, ZH Rosenberg, SH Giranda, VL Luo, Y Ng, SC
Citation: Xs. Liu et al., Downregulation of Akt1 inhibits anchorage-independent cell growth and induces apoptosis in cancer cells, NEOPLASIA, 3(4), 2001, pp. 278-286
New antimitotic agents with activity in multi-drug-resistant cell lines and in vivo efficacy in murine tumor models
Authors: Szczepankiewicz, BG Liu, G Jae, HS Tasker, AS Gunawardana, IW von Geldern, TW Gwaltney, SL Wu-Wong, JR Gehrke, L Chiou, WJ Credo, RB Alder, JD Nukkala, MA Zielinski, NA Jarvis, K Mollison, KW Frost, DJ Bauch, JL Hui, YH Claiborne, AK Li, Q Rosenberg, SH
Citation: Bg. Szczepankiewicz et al., New antimitotic agents with activity in multi-drug-resistant cell lines and in vivo efficacy in murine tumor models, J MED CHEM, 44(25), 2001, pp. 4416-4430
A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors
Authors: Tahir, SK Han, EKH Credo, B Jae, HS Pietenpol, JA Scatena, CD Wu-Wong, JSR Frost, D Sham, H Rosenberg, SH Ng, SC
Citation: Sk. Tahir et al., A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors, CANCER RES, 61(14), 2001, pp. 5480-5485
Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth
Authors: Chen, J Wu, W Tahir, SK Kroeger, PE Rosenberg, SH Cowsert, LM Bennett, F Krajewski, S Krajewska, M Welsh, K Reed, JC Ng, SC
Citation: J. Chen et al., Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth, NEOPLASIA, 2(3), 2000, pp. 235-241
Modulation of drug resistance by alpha-tubulin in paclitaxel-resistant human lung cancer cell lines
Authors: Han, EKH Gehrke, L Tahir, SK Credo, RB Cherian, SP Sham, H Rosenberg, SH Ng, SC
Citation: Ekh. Han et al., Modulation of drug resistance by alpha-tubulin in paclitaxel-resistant human lung cancer cell lines, EUR J CANC, 36(12), 2000, pp. 1565-1571
Rapid colchicine competition-binding scintillation proximity assay using biotin-labeled tubulin
Authors: Tahir, SK Kovar, P Rosenberg, SH Ng, SC
Citation: Sk. Tahir et al., Rapid colchicine competition-binding scintillation proximity assay using biotin-labeled tubulin, BIOTECHNIQU, 29(1), 2000, pp. 156-160
Survivin does not inhibit caspase-3 activity
Authors: Banks, DP Plescia, J Altieri, DC Chen, J Rosenberg, SH Zhang, HC Ng, SC
Citation: Dp. Banks et al., Survivin does not inhibit caspase-3 activity, BLOOD, 96(12), 2000, pp. 4002-4002
Potent and orally bioavailable noncysteine-containing inhibitors of protein farnesyltransferase
Authors: Augeri, DJ Janowick, D Kalvin, D Sullivan, G Larsen, J Dickman, D Ding, H Cohen, J Lee, J Warner, R Kovar, P Cherian, S Saeed, B Zhang, HC Tahir, S Ng, SC Sham, H Rosenberg, SH
Citation: Dj. Augeri et al., Potent and orally bioavailable noncysteine-containing inhibitors of protein farnesyltransferase, BIOORG MED, 9(8), 1999, pp. 1069-1074
Effect of novel CAAX peptidomimetic farnesyltransferase inhibitor on angiogenesis in vitro and in vivo
Authors: Gu, WZ Tahir, SK Wang, YC Zhang, HC Cherian, SP O'Connor, S Leal, JA Rosenberg, SH Ng, SC
Citation: Wz. Gu et al., Effect of novel CAAX peptidomimetic farnesyltransferase inhibitor on angiogenesis in vitro and in vivo, EUR J CANC, 35(9), 1999, pp. 1394-1401
Synergistic effect of paclitaxel and 4-hydroxytamoxifen on estrogen receptor-negative colon cancer and lung cancer cell lines
Authors: Gu, WZ Chen, ZH Tahir, SK Rosenberg, SH Ng, SC
Citation: Wz. Gu et al., Synergistic effect of paclitaxel and 4-hydroxytamoxifen on estrogen receptor-negative colon cancer and lung cancer cell lines, ANTI-CANC D, 10(10), 1999, pp. 895-901
Antimitotic agents
Authors: Li, Q Sham, HL Rosenberg, SH
Citation: Q. Li et al., Antimitotic agents, ANNU REP M, 34, 1999, pp. 139-148
Discovery of a series of cyclohexylethylamine-containing protein farnesyltransferase inhibitors exhibiting potent cellular activity
Authors: Henry, KJ Wasicak, J Tasker, AS Cohen, J Ewing, P Mitten, M Larsen, JJ Kalvin, DM Swenson, R Ng, SC Saeed, B Cherian, S Sham, H Rosenberg, SH
Citation: Kj. Henry et al., Discovery of a series of cyclohexylethylamine-containing protein farnesyltransferase inhibitors exhibiting potent cellular activity, J MED CHEM, 42(23), 1999, pp. 4844-4852
Second-generation peptidomimetic inhibitors of protein farnesyltransferasedemonstrating improved cellular potency and significant in vivo efficacy
Authors: O'Connor, SJ Barr, KJ Wang, L Sorensen, BK Tasker, AS Sham, H Ng, SC Cohen, J Devine, E Cherian, S Saeed, B Zhang, HC Lee, JY Warner, R Tahir, S Kovar, P Ewing, P Alder, J Mitten, M Leal, J Marsh, K Bauch, J Hoffman, DJ Sebti, SM Rosenberg, SH
Citation: Sj. O'Connor et al., Second-generation peptidomimetic inhibitors of protein farnesyltransferasedemonstrating improved cellular potency and significant in vivo efficacy, J MED CHEM, 42(18), 1999, pp. 3701-3710
Risultati: 1-13 |